Akanda Corp. (NASDAQ:AKAN) Short Interest Update

Akanda Corp. (NASDAQ:AKANGet Free Report) was the target of a large decline in short interest in June. As of June 30th, there was short interest totaling 18,178 shares, a decline of 87.0% from the June 15th total of 139,841 shares. Based on an average trading volume of 44,335 shares, the short-interest ratio is currently 0.4 days. Approximately 4.2% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Akanda to a “sell” rating in a research note on Saturday, May 30th. Weiss Ratings cut shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Akanda presently has an average rating of “Sell”.

Read Our Latest Analysis on Akanda

Akanda Stock Performance

NASDAQ:AKAN traded down $0.12 during trading hours on Monday, reaching $9.82. The company had a trading volume of 2,445 shares, compared to its average volume of 1,246,376. The stock has a 50-day moving average of $19.04 and a two-hundred day moving average of $10.68. Akanda has a one year low of $2.30 and a one year high of $209.02.

Akanda (NASDAQ:AKANGet Free Report) last issued its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) earnings per share (EPS) for the quarter.

Akanda Company Profile

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Recommended Stories

Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.